Global Large Scale Oligonucleotide Synthesis Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Large Scale Oligonucleotide Synthesis Service
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Large Scale Oligonucleotide Synthesis Service by Type
  • 1.3.1 Overview: Global Large Scale Oligonucleotide Synthesis Service Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Large Scale Oligonucleotide Synthesis Service Consumption Value Market Share by Type in 2022
  • 1.3.3 Gram Grade
  • 1.3.4 Microgram Grade
• 1.4 Global Large Scale Oligonucleotide Synthesis Service Market by Application
  • 1.4.1 Overview: Global Large Scale Oligonucleotide Synthesis Service Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Commercial
  • 1.4.3 Academic Research
• 1.5 Global Large Scale Oligonucleotide Synthesis Service Market Size & Forecast
• 1.6 Global Large Scale Oligonucleotide Synthesis Service Market Size and Forecast by Region
  • 1.6.1 Global Large Scale Oligonucleotide Synthesis Service Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Large Scale Oligonucleotide Synthesis Service Market Size by Region, (2018-2029)
  • 1.6.3 North America Large Scale Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Large Scale Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Large Scale Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.6 South America Large Scale Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Large Scale Oligonucleotide Synthesis Service Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 GenScript
  • 2.1.1 GenScript Details
  • 2.1.2 GenScript Major Business
  • 2.1.3 GenScript Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.1.4 GenScript Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 GenScript Recent Developments and Future Plans
• 2.2 Biol-Synthesis
  • 2.2.1 Biol-Synthesis Details
  • 2.2.2 Biol-Synthesis Major Business
  • 2.2.3 Biol-Synthesis Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.2.4 Biol-Synthesis Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Biol-Synthesis Recent Developments and Future Plans
• 2.3 Creative Biolabs
  • 2.3.1 Creative Biolabs Details
  • 2.3.2 Creative Biolabs Major Business
  • 2.3.3 Creative Biolabs Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.3.4 Creative Biolabs Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Creative Biolabs Recent Developments and Future Plans
• 2.4 Eurofins Genomics
  • 2.4.1 Eurofins Genomics Details
  • 2.4.2 Eurofins Genomics Major Business
  • 2.4.3 Eurofins Genomics Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.4.4 Eurofins Genomics Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Eurofins Genomics Recent Developments and Future Plans
• 2.5 Metabion
  • 2.5.1 Metabion Details
  • 2.5.2 Metabion Major Business
  • 2.5.3 Metabion Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.5.4 Metabion Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Metabion Recent Developments and Future Plans
• 2.6 Integrated DNA Technologies
  • 2.6.1 Integrated DNA Technologies Details
  • 2.6.2 Integrated DNA Technologies Major Business
  • 2.6.3 Integrated DNA Technologies Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.6.4 Integrated DNA Technologies Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Integrated DNA Technologies Recent Developments and Future Plans
• 2.7 Kaneka Eurogentec SA
  • 2.7.1 Kaneka Eurogentec SA Details
  • 2.7.2 Kaneka Eurogentec SA Major Business
  • 2.7.3 Kaneka Eurogentec SA Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.7.4 Kaneka Eurogentec SA Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Kaneka Eurogentec SA Recent Developments and Future Plans
• 2.8 TriLink
  • 2.8.1 TriLink Details
  • 2.8.2 TriLink Major Business
  • 2.8.3 TriLink Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.8.4 TriLink Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 TriLink Recent Developments and Future Plans
• 2.9 Synbio Technologies
  • 2.9.1 Synbio Technologies Details
  • 2.9.2 Synbio Technologies Major Business
  • 2.9.3 Synbio Technologies Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.9.4 Synbio Technologies Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Synbio Technologies Recent Developments and Future Plans
• 2.10 Glen Research
  • 2.10.1 Glen Research Details
  • 2.10.2 Glen Research Major Business
  • 2.10.3 Glen Research Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.10.4 Glen Research Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Glen Research Recent Developments and Future Plans
• 2.11 Bachem
  • 2.11.1 Bachem Details
  • 2.11.2 Bachem Major Business
  • 2.11.3 Bachem Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.11.4 Bachem Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Bachem Recent Developments and Future Plans
• 2.12 Sumitomo Chemical
  • 2.12.1 Sumitomo Chemical Details
  • 2.12.2 Sumitomo Chemical Major Business
  • 2.12.3 Sumitomo Chemical Large Scale Oligonucleotide Synthesis Service Product and Solutions
  • 2.12.4 Sumitomo Chemical Large Scale Oligonucleotide Synthesis Service Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Sumitomo Chemical Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Large Scale Oligonucleotide Synthesis Service Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Large Scale Oligonucleotide Synthesis Service by Company Revenue
  • 3.2.2 Top 3 Large Scale Oligonucleotide Synthesis Service Players Market Share in 2022
  • 3.2.3 Top 6 Large Scale Oligonucleotide Synthesis Service Players Market Share in 2022
• 3.3 Large Scale Oligonucleotide Synthesis Service Market: Overall Company Footprint Analysis
  • 3.3.1 Large Scale Oligonucleotide Synthesis Service Market: Region Footprint
  • 3.3.2 Large Scale Oligonucleotide Synthesis Service Market: Company Product Type Footprint
  • 3.3.3 Large Scale Oligonucleotide Synthesis Service Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Large Scale Oligonucleotide Synthesis Service Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Large Scale Oligonucleotide Synthesis Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Large Scale Oligonucleotide Synthesis Service Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Large Scale Oligonucleotide Synthesis Service Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Large Scale Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 6.2 North America Large Scale Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 6.3 North America Large Scale Oligonucleotide Synthesis Service Market Size by Country
  • 6.3.1 North America Large Scale Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 6.3.2 United States Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Large Scale Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 7.2 Europe Large Scale Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 7.3 Europe Large Scale Oligonucleotide Synthesis Service Market Size by Country
  • 7.3.1 Europe Large Scale Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.3 France Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Large Scale Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Large Scale Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Large Scale Oligonucleotide Synthesis Service Market Size by Region
  • 8.3.1 Asia-Pacific Large Scale Oligonucleotide Synthesis Service Consumption Value by Region (2018-2029)
  • 8.3.2 China Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.5 India Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Large Scale Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 9.2 South America Large Scale Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 9.3 South America Large Scale Oligonucleotide Synthesis Service Market Size by Country
  • 9.3.1 South America Large Scale Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Large Scale Oligonucleotide Synthesis Service Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Large Scale Oligonucleotide Synthesis Service Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Large Scale Oligonucleotide Synthesis Service Market Size by Country
  • 10.3.1 Middle East & Africa Large Scale Oligonucleotide Synthesis Service Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Large Scale Oligonucleotide Synthesis Service Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Large Scale Oligonucleotide Synthesis Service Market Drivers
• 11.2 Large Scale Oligonucleotide Synthesis Service Market Restraints
• 11.3 Large Scale Oligonucleotide Synthesis Service Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Large Scale Oligonucleotide Synthesis Service Industry Chain
• 12.2 Large Scale Oligonucleotide Synthesis Service Upstream Analysis
• 12.3 Large Scale Oligonucleotide Synthesis Service Midstream Analysis
• 12.4 Large Scale Oligonucleotide Synthesis Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source